Proto-Oncogene Proteins c-vav
"Proto-Oncogene Proteins c-vav" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins that are guanine nucleotide exchange factors for RHO GTPASES. They contain pleckstrin homology and SH2 domains, through which they function as signal transducing adaptor proteins.
| Descriptor ID |
D051567
|
| MeSH Number(s) |
D12.644.360.024.321 D12.644.360.325.300.099.750 D12.776.157.057.155 D12.776.476.024.407 D12.776.476.325.300.099.750 D12.776.624.664.700.198
|
| Concept/Terms |
Proto-Oncogene Proteins c-vav- Proto-Oncogene Proteins c-vav
- Proteins c-vav, Proto-Oncogene
- Proto Oncogene Proteins c vav
- c-vav, Proto-Oncogene Proteins
- Proto-Oncogene Protein vav
- Proto Oncogene Protein vav
- vav, Proto-Oncogene Protein
- vav Proto-Oncogene Protein
- Proto-Oncogene Protein, vav
- vav Proto Oncogene Protein
- c-vav Protein
- c vav Protein
- Proto-Oncogene Protein vav1
- Proto Oncogene Protein vav1
- vav1, Proto-Oncogene Protein
- vav Guanine-Nucleotide Exchange Factor
- vav Guanine Nucleotide Exchange Factor
- Proto-Oncogene Protein c-vav
- Proto Oncogene Protein c vav
- c-vav, Proto-Oncogene Protein
|
Below are MeSH descriptors whose meaning is more general than "Proto-Oncogene Proteins c-vav".
Below are MeSH descriptors whose meaning is more specific than "Proto-Oncogene Proteins c-vav".
This graph shows the total number of publications written about "Proto-Oncogene Proteins c-vav" by people in this website by year, and whether "Proto-Oncogene Proteins c-vav" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2002 | 0 | 2 | 2 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2011 | 0 | 2 | 2 |
| 2014 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Proto-Oncogene Proteins c-vav" by people in Profiles.
-
VAV3 mediates resistance to breast cancer endocrine therapy. Breast Cancer Res. 2014 May 28; 16(3):R53.
-
VE-cadherin trans-interactions modulate Rac activation and enhancement of lung endothelial barrier by iloprost. J Cell Physiol. 2012 Oct; 227(10):3405-16.
-
Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase. Proc Natl Acad Sci U S A. 2012 Jan 10; 109(2):E59-67.
-
Inhibition of the Rho GTPase, Rac1, decreases estrogen receptor levels and is a novel therapeutic strategy in breast cancer. Endocr Relat Cancer. 2011 Apr; 18(2):207-19.
-
Epac/Rap and PKA are novel mechanisms of ANP-induced Rac-mediated pulmonary endothelial barrier protection. J Cell Physiol. 2008 Jun; 215(3):715-24.
-
T-cell receptor-induced NF-kappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b. Mol Cell Biol. 2008 Apr; 28(7):2470-80.
-
Prostaglandins PGE(2) and PGI(2) promote endothelial barrier enhancement via PKA- and Epac1/Rap1-dependent Rac activation. Exp Cell Res. 2007 Jul 01; 313(11):2504-20.
-
HS1 functions as an essential actin-regulatory adaptor protein at the immune synapse. Immunity. 2006 Jun; 24(6):741-752.
-
Receptor-facilitated antigen presentation requires the recruitment of B cell linker protein to Igalpha. J Immunol. 2002 Mar 01; 168(5):2127-38.
-
Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells. Oncogene. 2002 Feb 21; 21(9):1423-33.